Christopher P. Lowe, C.F.O. and C.B.O at Anthera Pharmaceuticals Inc (ANTH), sold 15,000 shares at $7.66 ($115K) on 2012-02-01, disclosed to the SEC on 2012-02-03.
Scheduled sale ($115k) by C.F.O. and C.B.O under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRTX | SELL | 2021-08-18 | $4.1M | — | Filing → |
| CRTX | SELL | 2021-06-30 | $2.2M | — | Filing → |
| VINC | BUY | 2021-06-30 | $126K | — | Filing → |